1.Bladder cancer risk factors in Mongolians
Baasansuren S ; Shiirevnyamba A ; Myagmarsuren P ; Batmunkh G ; Amarsaikhan S ; Bayan-Undur D ; Munkhbat B
Mongolian Medical Sciences 2015;173(3):7-12
BACKGROUND: Bladder cancer is a cancer of significant morbidity and mortality in the worldwide. It is the second most common urological cancer in Mongolia. It is important to understand the risk factors of bladder cancer.We evaluated the association of smoking, alcohol intake, body mass index and other potential risk factors with bladder cancer incidence in Mongolians.MATERIALS AND METHODS: We analyzed data from a case-control study (116 histologically confirmed bladder cancer cases and 300 cancer-free healthy, age, gender-matched controls). All participants signed the consent form andfilled out the structured questionnaire including cigarette smoking, BMI, chronic urinary disease andalcohol drinking etc. Using logistic regression we estimated the covariate-adjusted odds ratio (OR) and95% confidence interval (CI) of the associations.RESULTS: Mean age of the patients with bladder cancer was 56±10.5 years and 79.3% male and 20.7% female.Cigarette smoking, history of urinary tract diseases and body mass index were associated with an increased risk of bladder cancer OR 6, 48 (95% CI 1, 61-1, 70), OR 80 (95% CI 1, 48-1, 93) and OR=9.8 (95% CI 2.32-2.91) respectively but not alcohol drinking OR 0, 26 (95% CI 1, 56-1, 66).CONCLUSIONS: The results suggest that cigarette smoking, history of urinary tract diseases and body mass indexincreased risk of bladder cancer in Mongolian patients.
2.Central serous chorioretinopathy
Temuulen B ; Baasansuren G ; Byambadorj M ; Uranchimeg D
Mongolian Journal of Health Sciences 2025;85(1):257-262
Background:
Central serous chorioretinopathy (CSCR) is described by researchers as a condition that results from fluid
under the retinal pigment epithelium, originating from the choroid of the eye. This disease usually affects the central part
of vision and may resolve on its own over time, though in some cases, it can persist for long periods or recur. In our country, there is a lack of research regarding this condition, which led to the motivation for gathering and reviewing existing
works on this topic.
Aim:
To collect and analyze a review of the studies on central serous chorioretinopathy (CSCR).
Methods:
We reviewed and analyzed literature related to CSCR published in electronic sources such as Thomson Reuters, PubMed-central database, and Google Scholar using literature review methods.
Results:
CSCR is most commonly seen in individuals aged 35-55 years, with a significantly higher prevalence in men
(9.9/100,000) compared to women (1.7/100,000). Researchers found that the prevalence of CSCR is nearly the same
among populations in Europe, Africa, and Asia. CSCR typically affects one eye, but it occurs in both eyes in up to 40%
of cases. Weenink A (2001) studied the family members of 27 patients with bilateral CSCR, finding that 52% of family
members had been diagnosed with CSCR, and 27.5% of them had chronic CSCR in at least one eye. This suggests a
potential genetic predisposition to CSCR. According to researchers, while CSCR can be diagnosed clinically, additional
imaging techniques like fluorescein angiography and optical coherence tomography are frequently used to rule out other
diagnoses and guide treatment.
Conclusion
CSCR generally has a favorable prognosis, but recurrences and its effects on visual function indicate the
need for effective management strategies. To maintain long-term visual improvement, it is essential to provide healthcare
services tailored to the patient’s specific conditions and risk factors.
3.Gene mutation associated with drug resistance in M.tuberculosis strains isolated from national TB prevalence survey in Mongolia
Tsetsegtuya B ; Baasansuren E ; Oyuntuya T ; Tserelmaa B ; Gundsuren Sh ; Tsolmon B ; Naranbat N ; Tsatsralt-Od B ; Buyankhishig B ; Naranzul D
Mongolian Medical Sciences 2019;187(1):3-10
Background:
According to the First National Tuberculosis (TB) Prevalence Survey in Mongolia the prevalence of
bacteriologically-confirmed pulmonary TB among adults was 559.6 (95% CI: 454.5–664.7) per 100000
population in 2014–2015. This was three times as high as previously estimated. Nationwide anti-tuberculosis (TB) drug resistance survey was conducted in 1999 and 2007 in Mongolia. Share of multidrug resistant TB (MDR-TB) cases among newly notified TB cases increased from 1.0% in 1999 to 1.4% in 2007. Accordingly, we aimed to perform drug susceptibility test on strains isolated from TB Prevalence Survey and to determine the prevalence of drug resistant TB.
Material and Methods:
All 242 MTB strains isolated from the survey TB cases were tested GenoTypeMTBDRplus test and conventional 1st line DST on solid medium.
Result:
Conventional DST and GenoTypeMTBDRplus tests done for 93.8% (227/242) of them and 6.2% (15/242) were tested by GenoTypeMTBDRplus only. A 61.6% (95%CI 55.3-67.4) of all cases were susceptible to first line anti-TB drugs, any drug resistance and MDR-TBdetected as 38.4% (95% CI 32.5-44.7)and 9.5% (95% CI 6.4-13.9), respectively. Prevalence of MDR-TB was7.8% (95% CI 4.9-12.4) among new and 17.9% (95% CI 9.0-32.7) among previously treated cases. The 64 strains were identified as a resistant to isoniazid, 32.8% (42/64) and 65.6% (21/64) were katG, and inhAmutation, respectively. One isolate (1.6%) was mutations in both the inhAand katGgenes.The predominant mutations detected in therpoB were S531L (91.3%) among rifampicin resistant isolates and the mutation in inhAwas C–15T (100%) and katG mutation was S315T1 (100%) among isoniazid-resistant isolates.
Conclusion
Prevalence of cases with DR-TB is high among prevalent TB cases, especially prevalence of MDR-TB among new cases. In comparison to previous studies, DR-TB cases seem to be increased. Rifampicin resistant strains have a mutation of the rpoBand resistance to isoniazid is predominantly associated with the inhA mutation.
4.ЭЛЭГНИЙ АРХАГ ҮРЭВСЭЛ, ЦИРРОЗЫН ҮЕД ЭЛЭГНИЙ ФИБРОЗЫН ЗЭРГИЙГ ХАТГАЛТЫН БУС СИЙВЭНГИЙН БИОМАРКЕРИЙН АРГААР ХАРЬЦУУЛАН СУДАЛСАН ДҮНГЭЭС
Ariunzaya B ; Badamsuren D ; Ulzmaa G ; Baasansuren B ; Nasantogtokh D ; Suvdaa B
Innovation 2017;11(2):16-18
BACKGROUND. HCV-infected and obesity related liver diseases are leading to increases
in the prevalence of advanced liver disease. So, studying liver disease, especially liver
fibrosis is crucial issue of today. In Mongolia digestive system disease is second causation
of non-communicable disease. Therefrom in last years hepatocellular carcinoma is most
common malignancy, first of all cancers in Mongolia. In response to acute or chronic liver
injury, hepatic fibrosis is the accumulation of extracellular matrix and ultimately leads to
cirrhosis. Cirrhosis is the end-stage of fibrosis, resulting in nodule formation that may lead
to altered hepatic function and blood flow. Defining the phase of liver fibrosis is crucial
for therapeutic choice prognosis, important role in monitoring treatment. At the present
time, use of direct and undirect biomarkers methods could be recommended for liver
fibrosis stage. The aim of this study is to determine liver fibrosis stage and to compare
undirect biomarkers in chronic viral hepatitis, cirrhosis. METHODS: 630 cases by chronic
viral hepatitis and cirrhosis at third central hospital in Mongolia from retrospectively reviewed
and analysed. The clinical data including AST, ALT, platelet count and INR were
recorded. APRI, FIB-4, AAR and FibroQ were calculated. RESULT: From all, males 42.06%
and females 57.94%, with mean age of 55.35±24.0, in 130 cases with chronic viral hepatitis
and 500 cases with cirrhosis. In cases of cirrhosis, mean value of platelet count, ALT,
AST, INR was 120.54±73.53, 104.55±500.22, 111.68±279.97, 2.19±10.45, respectively. And in
cases of chronic viral hepatitis platelet count mean value was 211.18±6.42.
APRI was detected <0.5 cutoff value (F0-F1) 11.7% non-fibrosis, 0.5-1.5 score (F2-F3) 27.5%
fibrosis, >1.5 cutoff value (F4) 60.8% cirrhosis. FIB-4 was determined <1.45 cutoff value
(F0-F1) 14.8% non-fibrosis, 1.45-3.25 score (F2-F3) 15.7% fibrosis, >3.25 cutoff value (F4)
69.5%, AAR was showed <0.4 cutoff value (F0-F1) 2.3% non-fibrosis, 0.4-1 score (F2-F3)
30.2% fibrosis, >1 cutoff value (F4) 67.5%. And FibroQ was detected <0.6 cutoff value (F0-
F1) 0.5% non-fibrosis, 0.6-2.6 score (F2-F3) 6% fibrosis, cutoff value 2.6< (F4) 93.5 cirrhosis.
In study liver fibrosis staging by APRI, AAR, FIB-4 and FibroQ score system, AAR was determined
fibrosis in 190 cases. CONCLUSION: Recorded data ALT, AST, INR in cases of
cirrhosis were detected 104.55±500.22, 111.68±279.97, 2.19±10.45, respectively. And in
cases of chronic hepatitis platelet count mean value was 211.18±6.42. APRI, AAR, FIB-4,
FibroQ was determined fibrosis 27.5%,30.16%,15.71% and 6.03%, respectively.
5.The results of genotype and drug resistance analysis of M. tuberculosis strains circulating in Mongolia, compared over a 10-year interval
Oyuntuya T ; Tsetsegtuya B ; Baasansuren B ; Akiko T ; Naranzul D ; Gantungalag G ; Mitarai S ; Buyankhishig B ; Sarantuya J
Mongolian Journal of Health Sciences 2025;85(1):67-73
Background:
Tuberculosis (TB) is a preventable and usually curable disease. Yet in 2022, TB was the world’s second
leading cause of death from a single infectious agent, after coronavirus disease (COVID-19)1.
Aim:
By reviving strains isolated at specific years over a 10-year interval and performing next-generation sequencing,
we can analyze their strain genotype, epidemiology, drug resistance, and dynamicsTherefore, this study was conducted
to examine the historical trends and dynamics of strain genotype, variants, and drug resistance of tuberculosis preserved
in the culture bank.
Materials and Methods::
Using a retrospective, laboratory-based research approach, 200 strains were randomly selected from over 1,000 diagnostic isolates preserved in the NTRL culture collection from 2010 and 2020. Whole-genome
sequencing (WGS) was performed using GridION from Oxford Nanopore Technologies (ONT, Oxford, UK) to analyze
these strains. The FastQ file was submitted to the International Mycobacterial Database. Strain genotypes, subtypes, gene
mutations of drug resistance, and resistance profiles were identified using TBprofiler, MTBseq, IQ-Tree (version 1.6.12),
and EPI2me software.
Results:
Of the tuberculosis strains selected for the study, 66.5% were from eight out of nine districts of Ulaanbaatar,
while 33.5% were sampled from 16 out of 21 provinces. Out of the strains analyzed, 83.9% (95% CI 78.7–89.1) belonged
to lineage 2 or the Beijing genotype, while 16.1% (95% CI 10.9–21.3) were lineage-4 or Euro-American genotype. While
the proportion of Beijing lineage strains was slightly higher and the Euro-American lineage strains slightly lower in rural
populations compared to urban populations, the difference in strain distribution between urban and rural areas was not
statistically significant (p=0.485). Among the Beijing lineage strains, only the modern Beijing sublineage (100%) was
identified. In contrast, the Euro-American lineage exhibited various sublineages: 4 (0.5%), 4.5 (1%), 4.1.2.1 (Haarlem,
3%), Latin American-Mediterranean (LAM, 7.5%), mainly T (3.5%), and S type (0.5%). Notably, the proportion of Lineage 2 strains increased from 80% in 2010 to 86% in 2020.
The overlap of the confidence intervals for 2010 (72.16%–87.84%) and 2020 (79.20%–92.80%) indicates that there has
been no significant change in the distribution of Mycobacterium tuberculosis lineages over time. The study revealed that
among the selected Mycobacterium tuberculosis strains, resistance rates to first-line anti-tuberculosis drugs were as follows: isoniazid (39%), rifampicin (21%), ethambutol (19%), and streptomycin (34%). Genotypic analysis indicated that
the Beijing lineage was predominantly associated with drug-resistant tuberculosis cases, including multidrug-resistant
(MDR), poly-drug-resistant, and mono-drug-resistant TB. Notably, the Beijing lineage accounted for 100% of pre-extensively drug-resistant (pre-XDR) TB cases. Within the Haarlem lineage, 33% were MDR-TB.
In the Latin American-Mediterranean (LAM) lineage, 13.3% were MDR-TB, 6.6% were poly-drug-resistant, and 13.3%
were mono-drug-resistant. Among the mainly T lineage, 42.8% exhibited mono-drug resistance. These findings suggest
that the distribution of M. tuberculosis lineages in the Mongolian population has remained relatively stable over time,
with no significant temporal changes.
Conclusion
The distribution of M. tuberculosis genotypes circulating among the population of Mongolia has remained
relatively stable over time, with no significant time-dependent changes. Additionally, no mutations associated with resistance to newly introduced anti-TB drugs were detected.
6.Fibular fixation in tibiofibular fractureses
Uranbileg B ; Badamgarav G ; Otgonsaikhan N ; Baasansuren Sh ; Erdenebileg A ; Batsukh O ; Naranbat L ; Sanchin U
Innovation 2020;14(2):72-76
Background:
Treatment of adult tibiofibular fractures, especially severely comminuted
fractures, is technically challenging due to the lack of reduction markers and difficulty in restoring
the alignment. Fixation of the fibula can facilitate reduction of the tibia fracture and restoration
of the lower extremity alignment.
Methods:
Between 2018-2019 we have operated on 50 patients who have lie on the same
plane of tibiafibular fractures. Measures of angulation were obtained from radiographs taken
immediately after the surgery, a second time 3 months later, and at 3-month follow-up. The
analysis was performed with STATA.
Results:
Fixating fractures of tibia and fibula at same level were not shown to have complications
on the development of nonunion including fibular shortening, hindfoot alignment, slow process of
nonunion and unstableness.
Conclusions
We recommend fibular fixation in all 50 distal fractures when both fractures lie on
the same plane and the tibial fracture is relatively stabilized.
7.The research review study result of craniometrical parameters of facial bone during fetal development
Enebish S ; Zoljargal P ; Batmunkh G ; Nomiungerel R ; Baasansuren S ; Dorjjagdag G ; Handin G ; Dolgorsuren A ; Erdenezaya O ; Nyamsurendejid D ; Juramt B ; Purevsuren Kh
Diagnosis 2024;109(2):15-21
Background:
Studying the human embryonic and fetal organ systems development patterns and determining their quantitative indicators is of scientific and practical importance in medicine and health in every nation.
Distortions and pathologies during the development of the embryo are the causes of congenital disabilities. Among the congenital malformations, facial malformations are the 3rd place, including cleft lip and palate in 70% and Srouzon's syndrome in 30%. In addition, abnormalities due to changes in the size, shape, and position of the jaw are also mentioned in the 2021.04.21 issue of Morphology magazine in the study "Morphometric parameters of the bones of the skull and face during the development of newborns and fetuses". In our country, Ariuntuul G (2005) determined that cleft lip and cleft palate occur at 0.76/1000 or 1 in 1314 live births, while Ayanga G (2012) found that it occurs at 1 in 1072 live births or 0.93/1000. Moreover, the eye cup dimensions of Mongolian fetuses aged 16 36 weeks have a positive linear relationship with the gestational age determined using ultrasound by Nandintsetseg B (2015) et al. Compared with the other countries, the eyecup is slightly wider, and the outer edge distance is similar, whereas the inner edge distance is shorter.
Purpose:
To summarize research work and determine the embryonic development of bones involved in the formation of the face and facial parts, the period of bone formation, the point of ossification, and the period of formation.
Methods:
During fetal development, human organ systems grow and develop at different rates but in a particular relationship. This feature of growth and development is also clearly observed in the structure of the head and facial bones, and the results of researchers who have studied this aspect are selected in the articles.
Results:
Embryonic and fetal development of bone are clinically significant not only from the point of view of its morphogenesis but also from the point of view of congenital disabilities.
Conclusion
In the analysis of the sources, most of the works on the prenatal period of the development of the same body have studied the development of specific structures of the face and facial area, such as the palatine bones and nasal bones, or have generally covered the development of particular systems in the embryo and fetus, and face, there are relatively few works that show the entire dynamics of growth and development of facial bones.
8.The effect of regulator proteins on the IFN-γ/TLR9 synergistic signal transduction
Baljinnyam T ; Khulan O ; Erkhembayar Sh ; Baasansuren E ; Jawkhlan B ; Batkhishig ; Enkhsaikhan L ; Galindew B ; Tsewelmaa N ; Baigalmaa B ; Hongorzul B ; Sodnomtsogt L ; Nyambayar D ; Batbaatar G ; Monhbat B ; Munkhtuwshin N ; Bilegtsaikhan Ts
Health Laboratory 2018;8(1):8-13
Introduction:
When human body encounters external pathogens primary/innate immunity cells are activated by recognizing them and secondary/adaptive immunity is activated consecutively. Immune cell surface receptors, called Toll-like receptors (TLRs) recognize and bind pathogens. In our previous study, we revealed that there is a synergistic action between TLR9 and IFN-γ signaling in the endothelial cells.
Purpose:
To determine the role of negative and positive regulatory proteins on the IFN-γ/TLR9 synergistic signaling pathway
Materials and Methods:
This study was held in the Core Laboratory, Science Technology Center, Mongolian National University of Medical Sciences (MNUMS). In this study, murine endothelial cell (END-D) culture was used. The negative and positive regulator protein expression was detected by Western blotting.
Result:
Result of immunoblotting assay indicated that CpG DNA enhanced IFN-γ positive regulator protein p38 phosphorylation in the endothelial cells. Treatment by TLR9 ligand CpG DNA and IFN-γ increased p38
activation in 0.5 hour and 1 hour. CpG DNA inhibited IFN-γ negative regulator SOCS1 protein expression in 4 hr and 8 hr. Therefore, TLR9 ligand CpG DNA increased IFN-γ signal transduction in the endothelial cell line.
Conclusion
TLR9 ligand CpG DNA has decreased IFN-γ negative regulator protein SOCS1 expression. CpG DNA has increased IFN-γ positive regulator protein p38 phosphorylation.
9.Role of negative regulators on the TLR7 ligand/IFN-γ signaling in the endothelial cells
Baasansuren E ; Javkhlan B ; Baljinnyam T ; Khulan U ; Batkhishig M ; Enkhsaikhan L ; Ulziisaikhan J ; Khongorzul B ; Baigalmaa B ; Galindev B ; Tsevelmaa N ; Sodnomtsogt L ; Nyambayar D ; Munkhtuvshin N ; Munkhbat B ; Bilegtsaikhan Ts
Health Laboratory 2018;8(1):14-18
Introduction:
Toll like receptors (TLRs) are a class of proteins that key role in the innate immune system. The SOCS1 and SHP2 proteins are negative-feed loop inhibitors of signaling of JAK/STAT and TLRs pathways.
Purpose:
To determine negative regulator protein activation which is activated through TLR7 ligand/IFN-γ signal transduction in endothelial cells.
Methods:
We used mouse aortic linear endothelial cell (END-D); protein expressio was detected by western blotting
Results:
We analyzed a time dependent stimulation effects of negative regulator proteins stimulated by TLR7 ligand/IFN-γ in endothelial cell cultures. Imiquimod of 10 μg/ml treatment of 1 hr was followed by 100 ng/ml IFN-γ stimulation for 1-8hr to analysis of negative regulator SOCS1 and SHP2 protein expression.
In untreated cells, there was low activations of negative regulator SOCS1 and SHP2 proteins. IFN-γ stimulation alone had increased SOCS1 and SHP2 protein expressions, also imiquimod treatment highly elevated SOCS1 and SHP2 expressions. However imiquimod and IFN-γ doubled treatment have decreased activation of negative regulator SOCS1 and SHP2 proteins. These findings suggest SOCS1 and SHP2 proteins are inhibitors in the TLR7 ligand/IFN-γ signaling.
Conclusion
Negative regulators, SOCS1 and SHP2 strongly suppressed activations of TLR7 ligand/IFN-γ signaling
10.The effect of TLR9 ligand on IFN-ү signaling
Erkhembayar Sh ; Battsetseg Ts ; Baljinnyam T ; Altai E ; Baasansuren E ; Javkhlan B ; Batkhishig M ; Dolgorsuren S ; Ulziisaikhan J ; Enkhsaikhan L ; Tsendmaa Ts ; Galindev B ; Khongorzul B ; Baigalmaa B ; Nyambayar D ; Munkhbat B ; Bilegtsaikhan Ts
Health Laboratory 2017;6(1):15-23
Introduction:
The aim of this research project is to elucidate the crosstalk of innate and adaptive immune reactions against the DNA containing bacteria.
:
This study held in the Core laboratory, Science Technology Center, Mongolian National University of
Medical Sciences (MNUMS). Murine aortal endothelial cells, END-D cultured and the cell viability checked by MTT assay. In addition, the NO production, protein and gene expression studied by Griess Reagent
assay, R.T-PCR and immunoblotting, respectively.
Results:
0.1µM, 1µM and 10µM of TLR9 ligand exhibited no cytotoxic action against the cells by MTT assay. IFN-ү alone induced NO production in END-D cells. In the other hand, TLR9 ligand at 0.1µM, 1µM and 10µM up-regulated IFN-ү induced NO production in dose dependent manner. RTPCR results exhibit that TLR9 ligand up regulates iNOS mRNA. Immunoblotting analysis showed the enhanced iNOS protein expression and phosphorylation of STAT1 in cells pre-treated with TLR9 ligand.
Discussion:
We have demonstrated CpG DNA, TLR9 ligand, up-regulates IFN-ү induced NO via enhanced IFN-ү signaling. The result of Western Blotting and RT-PCR support the up-regulation of NO. CpG DNA can be used as agent against virus and bacteria. Further research need to be conducted.
Conclusion
TLR9 ligand, CpG DNA up-regulates IFN-ү induced NO production in time and dose dependent manner. TLR9 ligand augments the expression of iNOS mRNA and STAT1 phosphorylation in response to IFN-ү.